Bio/Pharma News

Sanofi Pasteur and Immune Design Collaborate to Develop Herpes Simplex Virus Therapy

October 16, 2014

Sanofi Pasteur and Immune Design agree to jointly develop therapies through Phase II clinical trials.

FDA Grants Priority Review for Pfizer's HER2- Advanced Breast Cancer Treatment

October 14, 2014

Pfizer announced that it has received FDA Priority Review for palbociclib, in combination with letrozole, as a treatment for HER2- advanced breast cancer.

Endo to Acquire Auxilium Pharmaceuticals

October 10, 2014

Endo will acquire Auxilium Pharmaceuticals in a cash and stock transaction for approximately $2.6 billion.

Genentech Receives FDA Priority Review for Diabetic Retinopathy Treatment

October 09, 2014

FDA granted Genentech priority review for its diabetic retinopathy treatment, Lucentis.

Ebola Outbreak Sparks EMA Review of Experimental Ebola Treatments

September 26, 2014

In response to the Ebola outbreak, EMA has started reviewing Ebola treatments in the development pipeline.

MedImmune Receives Fast Track Designation for Development of Nosocomial Pneumonia Prevention

September 23, 2014

AstraZeneca's global biologics research group, MedImmune, received FDA Fast Track designation for MEDI3902, for the prevention of nosocomial pneumonia.

Avalon Ventures Announces the Launch of Two New Companies: Silarus Therapeutics and Thyritope Biosciences

September 23, 2014

Avalon Ventures and GSK add two more companies to their launch list of early-stage life-science companies.

Alchem International Commits to Tropane Alkaloid APIs

September 23, 2014

Alchem International announced that it will continue to market and support Tropane Alkaloid APIs despite earlier reports.

Merck KGaA Acquires Sigma-Aldrich for $17 Billion

September 22, 2014

Merck KGaA will expand the reach of its EMD Millipore division with the purchase of life-sciences company Sigma-Aldrich.

GSK Fined in China Bribery Scandal

September 19, 2014

GSK is found guilty of offering bribes to doctors and is fined $489 million.